6 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Immunology and Immunotherapy


We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment”
by Dimitrios C. Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Dimitra Foteinou, Ioannis-Alexios Koumprentziotis, Georgios Xynos and Helen Gogas
Cancers 2023, 15(10), 2718; https://doi.org/10.3390/cancers15102718
Available online: https://www.mdpi.com/2072-6694/15/10/2718

“Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events”
by Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan et al.
Cancers 2023, 15(5), 1629; https://doi.org/10.3390/cancers15051629
Available online: https://www.mdpi.com/2072-6694/15/5/1629

“Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes”
by Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang and Jae-Joon Kim
Cancers 2023, 15(8), 2383; https://doi.org/10.3390/cancers15082383
Available online: https://www.mdpi.com/2072-6694/15/8/2383

“Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma”
by Tatsuya Deguchi, Naoya Maekawa, Satoru Konnai, Ryo Owaki, Kenji Hosoya, Keitaro Morishita, Motoji Nakamura, Tomohiro Okagawa, Hiroto Takeuchi, Sangho Kim et al.
Cancers 2023, 15(11), 3013; https://doi.org/10.3390/cancers15113013
Available online: https://www.mdpi.com/2072-6694/15/11/3013

“Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis”
by Melissa M. De Meza, Willeke A. M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers et al.
Cancers 2023, 15(2), 409; https://doi.org/10.3390/cancers15020409  
Available online: https://www.mdpi.com/2072-6694/15/2/409

“Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma”
by Gitanjali Sharma, Marta C. Braga, Chiara Da Pieve, Wojciech Szopa, Tatjana Starzetz, Karl H. Plate, Wojciech Kaspera and Gabriela Kramer-Marek
Cancers 2023, 15(12), 3131; https://doi.org/10.3390/cancers15123131
Available online: https://www.mdpi.com/2072-6694/15/12/3131

Anticancer Immunity with Physical Treatment Modalities”
Edited by Dr. Sander Bekeschus
Submission deadline: 1 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/GWHKI53P66
Cancer and Immunomediated Inflammatory Diseases (IMIDs)”
Edited by Prof. Dr. Sandro Ardizzone
Submission deadline: 10 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/D63VX78S95

The Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion (Volume II)”
Edited by Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/4BPEBEU010
Immune Checkpoint Inhibitors for Urologic Cancers”
Edited by Dr. Panagiotis Vlachostergios
Submission deadline: 30 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/9LF513VT85

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Back to TopTop